Genome integrity: linking pluripotency and tumorgenicity

Wenbin Deng, Yang Xu

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Genome integrity is a fundamental issue in both cancer and stem cell biology. A series of recent studies revealed that a tumor suppressor p53, which is required for genome integrity, is critical also for stem cell pluripotency and reprogramming, further strengthening the fundamental link between cancer and pluripotency. p53 and other tumor suppressors might be barriers to reprogramming somatic cells for the generation of induced pluripotent stem cells (iPSCs), and simultaneously and systematically destroying these barriers would improve reprogramming efficiency. Therefore, it is also crucial to determine the tumorgenicity of the cells derived from iPSCs for any future therapeutic use.

Original languageEnglish (US)
Pages (from-to)425-427
Number of pages3
JournalTrends in Genetics
Volume25
Issue number10
DOIs
StatePublished - Oct 2009
Externally publishedYes

Fingerprint

Induced Pluripotent Stem Cells
Genome
Neoplasms
Neoplastic Stem Cells
Therapeutic Uses
Cell Biology
Stem Cells
Cellular Reprogramming

ASJC Scopus subject areas

  • Genetics

Cite this

Genome integrity : linking pluripotency and tumorgenicity. / Deng, Wenbin; Xu, Yang.

In: Trends in Genetics, Vol. 25, No. 10, 10.2009, p. 425-427.

Research output: Contribution to journalArticle

Deng, Wenbin ; Xu, Yang. / Genome integrity : linking pluripotency and tumorgenicity. In: Trends in Genetics. 2009 ; Vol. 25, No. 10. pp. 425-427.
@article{05f4857a57cb41659544888be21e7164,
title = "Genome integrity: linking pluripotency and tumorgenicity",
abstract = "Genome integrity is a fundamental issue in both cancer and stem cell biology. A series of recent studies revealed that a tumor suppressor p53, which is required for genome integrity, is critical also for stem cell pluripotency and reprogramming, further strengthening the fundamental link between cancer and pluripotency. p53 and other tumor suppressors might be barriers to reprogramming somatic cells for the generation of induced pluripotent stem cells (iPSCs), and simultaneously and systematically destroying these barriers would improve reprogramming efficiency. Therefore, it is also crucial to determine the tumorgenicity of the cells derived from iPSCs for any future therapeutic use.",
author = "Wenbin Deng and Yang Xu",
year = "2009",
month = "10",
doi = "10.1016/j.tig.2009.09.004",
language = "English (US)",
volume = "25",
pages = "425--427",
journal = "Trends in Genetics",
issn = "0168-9525",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Genome integrity

T2 - linking pluripotency and tumorgenicity

AU - Deng, Wenbin

AU - Xu, Yang

PY - 2009/10

Y1 - 2009/10

N2 - Genome integrity is a fundamental issue in both cancer and stem cell biology. A series of recent studies revealed that a tumor suppressor p53, which is required for genome integrity, is critical also for stem cell pluripotency and reprogramming, further strengthening the fundamental link between cancer and pluripotency. p53 and other tumor suppressors might be barriers to reprogramming somatic cells for the generation of induced pluripotent stem cells (iPSCs), and simultaneously and systematically destroying these barriers would improve reprogramming efficiency. Therefore, it is also crucial to determine the tumorgenicity of the cells derived from iPSCs for any future therapeutic use.

AB - Genome integrity is a fundamental issue in both cancer and stem cell biology. A series of recent studies revealed that a tumor suppressor p53, which is required for genome integrity, is critical also for stem cell pluripotency and reprogramming, further strengthening the fundamental link between cancer and pluripotency. p53 and other tumor suppressors might be barriers to reprogramming somatic cells for the generation of induced pluripotent stem cells (iPSCs), and simultaneously and systematically destroying these barriers would improve reprogramming efficiency. Therefore, it is also crucial to determine the tumorgenicity of the cells derived from iPSCs for any future therapeutic use.

UR - http://www.scopus.com/inward/record.url?scp=70349964673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349964673&partnerID=8YFLogxK

U2 - 10.1016/j.tig.2009.09.004

DO - 10.1016/j.tig.2009.09.004

M3 - Article

C2 - 19801173

AN - SCOPUS:70349964673

VL - 25

SP - 425

EP - 427

JO - Trends in Genetics

JF - Trends in Genetics

SN - 0168-9525

IS - 10

ER -